We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Cytiva Logo


Cytiva, envision a world in which access to life-changing therapies transforms human health. With a rich heritage dating back hundreds of years, their wealth of technical expertise and talent, a broad and deep portfolio and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.

Latest Cytiva Content

Scientists working in a lab

Track-Etched Membranes at Work: Case Studies in Diagnostics

This whitepaper explores three unique case studies, showing how TEMs can be applied in diagnostics. Learn how to fine tune pore size and density to reliably capture target cells, ensure quality manufacturing and benefit downstream analysis.
Lateral Flow Tests on iPad Screen

How To Troubleshoot Lateral Flow Tests

From challenges with cross-reactivities to issues with inconsistent results, these problems are well-known and proven techniques exist to address and troubleshoot them.
Nucleic acid tubes on a laptop screen

Your Guide to Mastering Magnetic Bead Characteristics

This infographic deciphers how each characteristic influences magnetic bead separation and explores strategies to achieve optimal performance.
Man in lab coat walking up stairs where each step on the staircase is an illustration of an assay chip

Considerations for Lateral-Flow Immunoassay Development

This brochure outlines components and protocol considerations for the design and optimization of lateral-flow immunoassays.
Cytiva Webinar

Lateral Flow Assays: Optimizing Fiber Pads in Test Development and Manufacture

Cellulose filters are manufactured from wood pulp or high-quality cotton linters treated to achieve a high alpha cellulose content. Glass microfiber filters, or glass fibers, are manufactured from borosilicate glass. These depth filters combine fast flow rates with high loading capacity and the retention of very fine particles, extending into the sub-micron range, and are used in multiple steps of a lateral-flow assay including the sample pad, blood separator, conjugate release and adsorption pad.

Join our webinar, hosted by Klaus Hochleitner, to take a detailed look at the raw materials, specified parameters and optimal uses for cellulose fiber and glass fiber pads in lateral flow tests.

In this webinar you will:
• Review the purposes of the different pads in lateral flow tests
• Understand the raw materials and specified parameters of cellulose fibers and glass fibers with special focus on thickness
• Review the guidelines for development and assay validation, including block-on-the-fly
• Determine the optimal uses for cellulose fiber and glass fiber pads
Purple strand of mRNA.
Industry Insight

Creating the Right Environment for mRNA To Thrive

Scott Ripley explores how realizing the potential of mRNA therapeutics will require the standardization of processes, manufacturing agility and collaboration between industry, academia and government bodies.

AKTA System
App Note / Case Study

Single-Use Technology Designed for Small Batches in Gene Therapy Manufacturing

But how do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused?
AAV Capsids

Achieve Baseline Separation of AAV Full and Empty Capsids for Multiple Serotypes

To meet these needs, we developed scalable capture and polishing chromatography steps for recombinant AAV. Here we highlight the polishing step.
Cytiva Webinar

Label-Free Protein Activity Quantification for Drug Production and QC

Biotherapeutic drugs are complex and can perform their function through interactions with more than one target molecule. During development and quality control, a range of analytical technologies are used to characterize biotherapeutic drugs in terms of their structural integrity and activity. Ligand-binding assays are relevant for characterization and quantitation of the functional drug, however current analytical approaches may no longer be sufficient for analysis of emerging drug modalities.
Biacore™ assays are based on ligand binding and used in development and characterization of drug product using active concentration measurements, target binding, potency (E50)
and Fc receptor (FcR) analysis.
Cytiva Webinar Technology Networks 4th April 2024

Lateral Flow Assays: Characterizing Antibodies Using SPR Technology

This webinar will review how kinetic characterization of biological interactions can guide the selection of best-in-class detector molecules to enhance lateral flow diagnostics and outline the benefits of characterizing and selecting your lateral flow antibodies using SPR technology.